TRXC
TransEnterix Inc
Halal Rating :
Last Price
$0.35
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Exchange
Next Earnings Date
Asensus Surgical, Inc. (formerly TransEnterix, Inc.) is a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™. The company is focused on the development and commercialization of the Senhance® Surgical System, a digital laparoscopic platform that enhances minimally invasive surgery.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $2.21m | $26.07m | - | $321000.0 | 0.00% | 1.23% |
| March 31, 2024 | $1.12m | $25.76m | - | - | 0.00% | 0.00% |
| Dec. 31, 2023 | $5.43m | $21.43m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate TransEnterix Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.